<SEC-DOCUMENT>0000899243-22-029662-index.html : 20220824
<SEC-HEADER>0000899243-22-029662.hdr.sgml : 20220824
<ACCEPTANCE-DATETIME>20220824202223
ACCESSION NUMBER:		0000899243-22-029662
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220822
FILED AS OF DATE:		20220824
DATE AS OF CHANGE:		20220824

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			RAMSAY DAVID A
		CENTRAL INDEX KEY:			0001283292

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		221192711

	MAIL ADDRESS:	
		STREET 1:		HALOZYME THERAPEUTICS, INC.
		STREET 2:		11588 SORRENTO VALLEY ROAD, #17
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		201 JONES ROAD, SUITE 400
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-715-3600

	MAIL ADDRESS:	
		STREET 1:		201 JONES ROAD, SUITE 400
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>